Big Pharma tries new prescription

The Wall Street Journal is reporting that big pharmaceutical companies are focusing blockbuster drug research on drugs that effect small groups of patients.

Pfizer, for instance, is researching a cancer drug that shows promise fighting the disease, but only for 6,000 people with a genetic anomaly

Read more at the Wall Street Journal.